JPMorgan Starts Aegerion Pharmaceuticals (AEGR) at Overweight
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Price: $1.97 --0%
Rating Summary:
8 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 17
Rating Summary:
8 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 17
Join SI Premium – FREE
JPMorgan initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Overweight. PT $22.00.
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $14.93 yesterday.
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $14.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Reformation Inc (REF) at Overweight
- Morgan Stanley Starts Reformation Inc (REF) at Equalweight
- Piper Sandler Starts Jersey Mike's Subs (JMKE) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
